Lentiviral-mediated IDO1 overexpression was conducted to investigate the potential oncogenic role of IDO1 in U87 and LN229 cells because GBM cells barely express IDO1 (Fig. S1A, B). This evidence concerns the gene IDO1 and glioblastoma.